跳至主要内容
临床试验/ACTRN12616000709448
ACTRN12616000709448已完成未知

Investigation of endothelial toxicity after allogeneic haematopoietic stem cell transplantation

Fiona Stanley Hospital0 个研究点目标入组 30 人开始时间: 2016年5月27日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
16 Years 至 70 Years(—)
性别
All

入选标准

  • 1.Completed work-up and planned to proceed with allogeneic HSCT at Fiona Stanley Hospital
  • 2.Has had sufficient work-up to enable haematopoietic cell transplantation-specific comorbidity index (HCT-CI) to be calculated (minimum: history and examination, lung function studies, assessment of cardiac ejection fraction)
  • 3.Will receive one of the following conditioning regimens: busulfan + cyclophosphamide, TBI + cyclophosphamide or fludarabine + melphalan
  • 4.Will receive GVHD prophylaxis with a calcineurin inhibitor (cyclosporine or tacrolimus) and short course methotrexate, with or without ATG
  • 5.Provides informed consent to participate in the study

排除标准

  • 1.Incomplete pre-transplant work-up (see inclusion criteria 2 above)
  • 2.Will receive a conditioning regimen or GVHD prophylaxis regimen other than those specified in the inclusion criteria

研究者

相似试验